“I am pleased to see that so many stayed with us and followed the whole program”, says Hanne Mette Dyrlie Kristensen. “I believe this is due to the quality of our speakers and panelist and to the program as a whole.” One hundred participants joined The Life Science Cluster Day on November 24th.
See the recording from the webinar:
Part 1: https://youtu.be/p3avukzBdOU
Lotte Skolem, Director of Product & Technology at Aker BioMarine, was the conference host and guide through the conference program.
“The best possible conditions”
“The Norwegian Government will do what we can to give our life science industries and all other export industries the best possible conditions to develop both products, but also to access markets.” Stated State Secretary Lucie Katrine Sunde-Eidem in in her opening remarks at The Life Science Cluster Day.
Vice Mayor for Business Development and Public Ownership in the City of Oslo, Victoria Marie Evensen gave her greeting to the conference and highlighted the potential of Life Sciences and Oslo Science City. “We see exciting potential in the life sciences which is well poised in finding new innovative solutions to many of the challenges our society faces.”
Norwegian companies in international markets
Edel Anne Norderhus, Director VMRD PHARMAQ, Biologics, Therapeutics, Diagnostics at PHARMAQ part of Zoetis gave us her insights on how to build a profitable industry in Norway and beyond, combining marine needs and health knowledge.
Erling Sundrehagen, Chief Scientific Officer, and Torsten Knüttel, Vice President for Research and Development at Gentian Diagnostics gave in their presentation “Producing in Norway and how to reach export markets” three advise on how to be successful internationally: 1. Create marked pull, 2. Have a global mindset and 3. Think global and act local.
Big corporations and their role in the ecosystem
Rounding up the first section of the event, Christine Fløysand moderated a panel discussion on big corporations and their role in the ecosystem. The panellists were:
- Marije Oostindjer (Chief Advisor Bioprocesses and Business Strategy), Norilia AS
- Frode Nakkim (Communications, Public Affairs and Sustainability Manager), Bayer AS
- Tove Flem Jacobsen (Global Program Leader), GE Healthcare AS
- Svein Olaf Hustvedt (Head of Research & Development, Global Omega-3), BASF AS
Private investments in the Life Science Industry
Aitana Peire and Øivind Enger shared experience and advice in an informative dialog on
what they are looking for when investing in companies within the life science sectors. Aitana Peire is Investment Manager at Canica and Øivind Enger is a partner and investment advisor in Sarsia Seed.
A driving force for Nordic collaboration
Collaboration with other the other Nordic countries is one key to unleash the potential of life science. “All of the five countries are centres of excellence in different parts of life science and we complete each other in a very nice way,” says Helena Strigård, CEO of SwedenBIO, in her talk on international business development.
Future oriented industrial production
Håvard Sletta, Research manager of Group of Biotechnology, Department of Biotechnology and nanomedicine, SINTEF Industry gave an introduction to SFI – Industrial Biotechnology. He also looked into the industrial potential in seaweed, and the opportunities for Norway in future medicine.
From Science to business – Vaccibody as a case
Vaccibody is probably the most spoken of start-up this fall as they entered into a collaboration agreement with Genentech. Agnete Fredriksen, Co-founder, President & Chief Scientific Officer gave the story of Vaccibody from the very beginning. The mistakes and the most important strategic moves.
How can higher education in Norway strengthen the life science sector?
The very last stop on the agenda was a panel discussion about building competitive strengths for the future. And the question the panellists Carl Henrik Gørbitz from UiO:Life Science and Anne Berit Walter from Oslo Met were asked to answer was: How can higher education in Norway strengthen the life science sector? The moderator for this discussion was Elise Ramse. Elise is Head of People & Organization in Novartis.